Sinopharm
1099.HK
#2529
Rank
โ‚น683.96 B
Marketcap
โ‚น219.17
Share price
0.28%
Change (1 day)
11.41%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Revenue for Sinopharm (1099.HK)

Revenue in 2024: โ‚น7.754 Trillion

According to Sinopharm's latest financial reports the company's current revenue (TTM ) is โ‚น7.754 Trillion. In 2024 the company made a revenue of โ‚น7.754 Trillion a decrease over the revenue in the year 2023 that were of โ‚น8.171 Trillion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sinopharm from 2006 to 2024

Annual revenue

Year Revenue Change
2024โ‚น7.754 T-5.1%
2023โ‚น8.171 T5.42%
2022โ‚น7.751 T-2.1%
2021โ‚น7.917 T16.85%
2020โ‚น6.775 T14.95%
2019โ‚น5.894 T21.52%
2018โ‚น4.850 T5.93%
2017โ‚น4.578 T27.22%
2016โ‚น3.599 T5.37%
2015โ‚น3.415 T9.14%
2014โ‚น3.129 T17.22%
2013โ‚น2.669 T25.94%
2012โ‚น2.119 T34.61%
2011โ‚น1.574 T55.34%
2010โ‚น1.013 T35.79%
2009โ‚น746.55 B37.56%
2008โ‚น542.72 B31.43%
2007โ‚น412.94 B40.26%
2006โ‚น294.41 B